Interim Guidelines for Biosafety and COVID-19: Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19): May 11, 2020

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated May 11, 2020
  
  Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling SARS-CoV-2 specimens are provided below. For additional information on handling SARS-CoV-2 specimens, refer to the Laboratory Biosafety Frequently Asked Questions.
  
  General Guidance -- Routine Viral Testing -- Decentralized and Point of Care Testing -- Procedures with a High Likelihood to Generate Droplets or Aerosols -- Environmental Specimen Testing -- Virus Isolation -- Decontamination -- Laboratory Waste Management -- Specimen Packing and Shipping -- Resources.
  
  
• Subjects:
  Clinical Laboratory Techniques Containment Of Biohazards Coronavirus Infections/diagnosis COVID-19 Testing Respiratory Tract Infections/diagnosis Safety Specimen Handling
• Series:
  Coronavirus Disease 2019 (COVID-19)
• Document Type:
  Text
• Genre:
  Guideline
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:312eb320409366c48ac409da4d9312595e7c7a9f6b7f8bd9dcf8a890a8bdfce2eeea4d7e40e095e9dcdae951ae3f1e175c148d33e3b28195cc06840d057decc1
• Download URL:
  https://stacks.cdc.gov/view/cdc/88177/cdc_88177_DS1.pdf
• File Type:
  [PDF - 96.43 KB ]